NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE

NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE was reported 1093 times

NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VITREOUS ABSCESS 1 0.0909
1 CORNEAL ENDOTHELIAL CELL LOSS 2 0.0294
2 VITAMIN B1 INCREASED 1 0.0213
3 CHOROIDAL DYSTROPHY 1 0.0208
4 INFUSION SITE DRYNESS 1 0.0185
5 EXPOSURE VIA MUCOSA 1 0.0167
6 RUBELLA 1 0.0088
7 VITREOUS ADHESIONS 1 0.0087
8 ANTERIOR CHAMBER FIBRIN 1 0.0078
9 KERATITIS FUNGAL 1 0.0048
10 EYELASH DISCOLOURATION 1 0.0046
11 CONJUNCTIVITIS VIRAL 1 0.0038
12 SCLERAL DISORDER 1 0.0037
13 CHEMICAL BURNS OF EYE 1 0.0036
14 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
15 PHARYNGEAL HYPOAESTHESIA 3 0.0032
16 FOREIGN BODY IN EYE 3 0.0031
17 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
18 KERATIC PRECIPITATES 1 0.0021
19 INFUSION SITE ABSCESS 1 0.0020
20 APPLICATION SITE INFECTION 1 0.0020
21 IRIS ADHESIONS 1 0.0019
22 SUPERFICIAL INJURY OF EYE 2 0.0018
23 OCULAR TOXICITY 2 0.0018
24 CORNEAL EPITHELIUM DEFECT 1 0.0017
25 OTORRHOEA 3 0.0017
26 NASAL CRUSTING 1 0.0015
27 EAR HAEMORRHAGE 3 0.0015
28 CORNEAL ABRASION 2 0.0015
29 EAR SWELLING 3 0.0014
30 PRODUCT DROPPER ISSUE 1 0.0013
31 BREAST OPERATION 1 0.0012
32 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
33 CYSTOID MACULAR OEDEMA 2 0.0011
34 EYELID MARGIN CRUSTING 3 0.0010
35 EYELID RASH 1 0.0010
36 MASTOIDITIS 1 0.0010
37 STOMA COMPLICATION 1 0.0010
38 CONJUNCTIVAL OEDEMA 1 0.0010
39 PNEUMONIA STREPTOCOCCAL 1 0.0009
40 HALO VISION 1 0.0009
41 EYELID DISORDER 2 0.0009
42 INSTILLATION SITE IRRITATION 1 0.0008
43 EYELID SKIN DRYNESS 1 0.0008
44 EYELID IRRITATION 2 0.0008
45 HERPES OPHTHALMIC 1 0.0008
46 EYE IRRITATION 41 0.0007
47 PRODUCT CONTAINER ISSUE 6 0.0007
48 HORDEOLUM 3 0.0007
49 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
50 CONJUNCTIVITIS ALLERGIC 1 0.0007
51 EYE ALLERGY 1 0.0006
52 NIGHT BLINDNESS 1 0.0006
53 RETINAL THICKENING 1 0.0006
54 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
55 VERTIGO POSITIONAL 1 0.0006
56 INFUSION SITE DISCHARGE 1 0.0006
57 ERYTHEMA OF EYELID 3 0.0006
58 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
59 VITRITIS 1 0.0005
60 OCULAR HYPERTENSION 1 0.0005
61 OCULAR HYPERAEMIA 23 0.0005
62 SWELLING OF EYELID 3 0.0005
63 ABNORMAL SENSATION IN EYE 2 0.0005
64 CORNEAL OEDEMA 1 0.0004
65 INFUSION SITE INFECTION 1 0.0004
66 PRODUCT PACKAGING CONFUSION 1 0.0004
67 INJECTION SITE ABSCESS 1 0.0004
68 EYE PAIN 22 0.0004
69 EAR DISCOMFORT 4 0.0004
70 BRUXISM 2 0.0004
71 RESPIRATORY SYMPTOM 1 0.0004
72 EYELID OEDEMA 4 0.0003
73 FIBROSIS 1 0.0003
74 INFUSION SITE PRURITUS 1 0.0003
75 FOREIGN BODY SENSATION IN EYES 2 0.0003
76 SKIN EROSION 1 0.0003
77 INFUSION SITE HAEMORRHAGE 1 0.0003
78 SKIN INJURY 1 0.0003
79 EYE SWELLING 11 0.0003
80 GRANULOMA 1 0.0003
81 EYE DISCHARGE 3 0.0003
82 LOGORRHOEA 1 0.0003
83 HYPERACUSIS 1 0.0003
84 OCULAR DISCOMFORT 3 0.0003
85 EYE INFECTION 3 0.0003
86 BLEPHARITIS 1 0.0002
87 EYE PRURITUS 8 0.0002
88 PURULENT DISCHARGE 1 0.0002
89 ADVERSE REACTION 3 0.0002
90 PRODUCT TASTE ABNORMAL 3 0.0002
91 HAEMOGLOBIN INCREASED 1 0.0002
92 PHOTOPHOBIA 4 0.0002
93 EAR PAIN 4 0.0002
94 HYPERVOLAEMIA 1 0.0002
95 KLEBSIELLA INFECTION 1 0.0002
96 WEIGHT LOSS POOR 1 0.0002
97 ENDOCARDITIS 1 0.0002
98 DERMATITIS 4 0.0002
99 VISION BLURRED 26 0.0002
100 ANORECTAL DISCOMFORT 1 0.0002
101 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
102 DEAFNESS UNILATERAL 1 0.0002
103 PRODUCT LEAKAGE 1 0.0002
104 SCAB 2 0.0002
105 NEUROLOGICAL SYMPTOM 1 0.0002
106 NASAL DRYNESS 1 0.0002
107 INFUSION SITE SWELLING 1 0.0002
108 INTRAOCULAR PRESSURE INCREASED 2 0.0002
109 INFUSION SITE PAIN 2 0.0002
110 POSTOPERATIVE WOUND INFECTION 1 0.0001
111 WRONG PRODUCT ADMINISTERED 1 0.0001
112 EYE MOVEMENT DISORDER 1 0.0001
113 BLINDNESS TRANSIENT 1 0.0001
114 FEELING DRUNK 1 0.0001
115 DRUG DISPENSING ERROR 2 0.0001
116 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
117 FRUSTRATION TOLERANCE DECREASED 1 0.0001
118 ABNORMAL FAECES 1 0.0001
119 SENSATION OF FOREIGN BODY 1 0.0001
120 INFUSION SITE ERYTHEMA 1 0.0001
121 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
122 WRONG DRUG ADMINISTERED 1 0.0001
123 NERVE COMPRESSION 1 0.0001
124 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
125 CONJUNCTIVITIS 2 0.0001
126 ARTERIOSCLEROSIS 1 0.0001
127 PRODUCT PACKAGING ISSUE 1 0.0001
128 EYE INFLAMMATION 1 0.0001
129 DRY EYE 5 0.0001
130 LACRIMATION INCREASED 3 0.0001
131 INITIAL INSOMNIA 1 0.0001
132 SKIN LACERATION 1 0.0001
133 PRODUCT DISPENSING ERROR 2 0.0001
134 PULMONARY THROMBOSIS 1 0.0001
135 GASTROINTESTINAL PAIN 1 0.0001
136 VISUAL IMPAIRMENT 11 0.0001
137 MADAROSIS 1 0.0001
138 NO THERAPEUTIC RESPONSE 1 0.0001
139 SPINAL OPERATION 1 0.0001
140 GENERALISED OEDEMA 1 0.0001
141 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
142 EYE HAEMORRHAGE 1 0.0001
143 MASS 1 0.0001
144 HYPERSENSITIVITY 13 0.0001
145 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
146 SKIN HAEMORRHAGE 1 0.0001
147 THROAT IRRITATION 3 0.0001
148 PHARYNGEAL OEDEMA 1 0.0001
149 THERAPY PARTIAL RESPONDER 1 0.0001
150 PRODUCT USE COMPLAINT 1 0.0001
151 RESPIRATORY TRACT CONGESTION 1 0.0001
152 EYE DISORDER 2 0.0001
153 HEMIPARESIS 1 0.0001
154 PRODUCT QUALITY ISSUE 8 0.0001
155 MUSCULOSKELETAL DISCOMFORT 1 0.0001
156 THIRST 1 0.0001
157 TOOTHACHE 1 0.0001
158 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
159 POST PROCEDURAL COMPLICATION 1 0.0001
160 PULMONARY HYPERTENSION 1 0.0000
161 EATING DISORDER 1 0.0000
162 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
163 SWELLING FACE 3 0.0000
164 CONDITION AGGRAVATED 14 0.0000
165 HEART RATE IRREGULAR 1 0.0000
166 PRODUCT AVAILABILITY ISSUE 1 0.0000
167 SKIN DISCOLOURATION 2 0.0000
168 PERICARDIAL EFFUSION 1 0.0000
169 OROPHARYNGEAL PAIN 4 0.0000
170 NEURALGIA 1 0.0000
171 EXPOSURE VIA SKIN CONTACT 1 0.0000
172 DIPLOPIA 1 0.0000
173 DEAFNESS 1 0.0000
174 EAR INFECTION 1 0.0000
175 LIMB INJURY 1 0.0000
176 ABNORMAL DREAMS 1 0.0000
177 LIVER FUNCTION TEST ABNORMAL 1 0.0000
178 BONE PAIN 2 0.0000
179 VERTIGO 2 0.0000
180 HIP FRACTURE 1 0.0000
181 STAPHYLOCOCCAL INFECTION 1 0.0000
182 VISUAL ACUITY REDUCED 1 0.0000
183 CHEST DISCOMFORT 3 0.0000
184 DEVICE USE ERROR 1 0.0000
185 BURNING SENSATION 2 0.0000
186 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
187 DYSURIA 1 0.0000
188 INJECTION SITE MASS 1 0.0000
189 HOT FLUSH 2 0.0000
190 INJECTION SITE HAEMORRHAGE 2 0.0000
191 DRY MOUTH 2 0.0000
192 BLINDNESS 1 0.0000
193 POLLAKIURIA 1 0.0000
194 PRODUCT DOSE OMISSION ISSUE 7 0.0000
195 PRURITUS 9 0.0000
196 HYPOACUSIS 1 0.0000
197 DRY SKIN 3 0.0000
198 THERAPY NON-RESPONDER 1 0.0000
199 SKIN IRRITATION 1 0.0000
200 PRODUCT USE ISSUE 4 0.0000
201 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
202 INTERSTITIAL LUNG DISEASE 1 0.0000
203 ATRIAL FIBRILLATION 2 0.0000
204 FLUID RETENTION 1 0.0000
205 PERIPHERAL SWELLING 3 0.0000
206 DERMATITIS ATOPIC 1 0.0000
207 DRUG EFFECT DECREASED 1 0.0000
208 RASH PRURITIC 1 0.0000
209 OEDEMA 1 0.0000
210 RASH 8 0.0000
211 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
212 COUGH 5 0.0000
213 INCORRECT DOSE ADMINISTERED 4 0.0000
214 LETHARGY 1 0.0000
215 PRODUCT SUBSTITUTION ISSUE 1 0.0000
216 SURGERY 1 0.0000
217 CATARACT 1 0.0000
218 IRRITABILITY 1 0.0000
219 DISCOMFORT 1 0.0000
220 OFF LABEL USE 14 0.0000
221 DEEP VEIN THROMBOSIS 1 0.0000
222 NEOPLASM MALIGNANT 1 0.0000
223 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
224 ERYTHEMA 3 0.0000
225 INJURY 1 0.0000
226 THERAPY INTERRUPTED 1 0.0000
227 SKIN BURNING SENSATION 1 0.0000
228 BRONCHITIS 1 0.0000
229 EPISTAXIS 1 0.0000
230 HYPOAESTHESIA 2 0.0000
231 UNEVALUABLE EVENT 1 0.0000
232 ACNE 1 0.0000
233 CHRONIC KIDNEY DISEASE 1 0.0000
234 DIABETES MELLITUS 1 0.0000
235 INJECTION SITE SWELLING 1 0.0000
236 DECREASED APPETITE 3 0.0000
237 ARTHRITIS 1 0.0000
238 INJECTION SITE BRUISING 1 0.0000
239 FEELING ABNORMAL 3 0.0000
240 CARDIAC ARREST 1 0.0000
241 TREATMENT FAILURE 1 0.0000
242 BALANCE DISORDER 1 0.0000
243 PRODUCT STORAGE ERROR 1 0.0000
244 INTENTIONAL PRODUCT MISUSE 1 0.0000
245 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
246 COVID-19 2 0.0000
247 ADVERSE DRUG REACTION 1 0.0000
248 SUICIDAL IDEATION 1 0.0000
249 MUSCLE SPASMS 2 0.0000
250 NASOPHARYNGITIS 2 0.0000
251 PULMONARY EMBOLISM 1 0.0000
252 MIGRAINE 1 0.0000
253 DRUG INTOLERANCE 1 0.0000
254 PAIN IN EXTREMITY 3 0.0000
255 HEART RATE INCREASED 1 0.0000
256 SYNCOPE 1 0.0000
257 PAIN 6 0.0000
258 HAEMOGLOBIN DECREASED 1 0.0000
259 OVERDOSE 2 0.0000
260 INFLUENZA 1 0.0000
261 WEIGHT INCREASED 2 0.0000
262 DYSPNOEA 5 0.0000
263 MUSCULAR WEAKNESS 1 0.0000
264 VOMITING 4 0.0000
265 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
266 DIZZINESS 4 0.0000
267 HYPERHIDROSIS 1 0.0000
268 ANXIETY 2 0.0000
269 MALAISE 3 0.0000
270 DRUG INEFFECTIVE 9 0.0000
271 INJECTION SITE PAIN 2 0.0000
272 HOSPITALISATION 1 0.0000
273 FATIGUE 5 0.0000
274 NAUSEA 5 0.0000
275 DRUG DEPENDENCE 1 0.0000
276 DIARRHOEA 4 0.0000
277 PNEUMONIA 2 0.0000
278 URTICARIA 1 0.0000
279 ABDOMINAL DISCOMFORT 1 0.0000
280 MYALGIA 1 0.0000
281 MYOCARDIAL INFARCTION 1 0.0000
282 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
283 NO ADVERSE EVENT 1 0.0000
284 CHEST PAIN 1 0.0000
285 ASTHENIA 2 0.0000
286 GAIT DISTURBANCE 1 0.0000
287 HYPOTENSION 1 0.0000
288 SOMNOLENCE 1 0.0000
289 ABDOMINAL PAIN UPPER 1 0.0000
290 HYPERTENSION 1 0.0000
291 CONSTIPATION 1 0.0000
292 BACK PAIN 1 0.0000
293 ABDOMINAL PAIN 1 0.0000
294 WEIGHT DECREASED 1 0.0000
295 HEADACHE 2 0.0000
296 FALL 1 0.0000
297 ARTHRALGIA 1 0.0000
298 DEATH 2 0.0000